45 results
Page 2 of 3
POS AM
qxtz4p8jzvahdtl8zyn
9 Mar 22
Prospectus update (post-effective amendment)
8:40pm
424B3
pny4dp yghb6gmakp
11 Feb 22
Prospectus supplement
9:00am
D
iz48ft76i4gm 5z3m70
20 Jan 22
$10M in equity / options, sold $10M, 1 investor
8:18am
POS AM
ub9bt75242
24 Mar 21
Prospectus update (post-effective amendment)
9:17am
D
jw2pb1rdrbh yv0
25 Feb 21
$495K in equity / options, sold $495K, 1 investor
12:00am
D
4eavboql528tslvo
7 Oct 20
$1.5M in equity / options, sold $1.5M, 8 investors
9:03pm
424B4
gn603v
28 Sep 20
Prospectus supplement with pricing info
4:56pm
8-K
EX-99.1
v2idbrafd otmteqfv13
26 Aug 20
GeoVax Appoints Mark J. Newman, Ph.D. Chief Scientific Officer
5:16pm
8-K
fnj8evkrf4ky a56xi
26 Aug 20
GeoVax Appoints Mark J. Newman, Ph.D. Chief Scientific Officer
5:16pm
D
ohtgd159
6 Jul 20
$2.4M in debt / options, sold $2.4M, 2 investors
2:16pm
D/A
qesrbygpx
1 Nov 19
$3.26M in equity, sold $3.26M, 2 investors
11:54am
D/A
2k8h6
1 Nov 19
$700K in equity, sold $700K, 2 investors
11:40am